Quality Systems Reg Guidance Exceeds Statutory Authority, HIMA Says
This article was originally published in The Gray Sheet
Executive Summary
The design control provisions in FDA's draft guidance on quality system regulation (QSR) information requirements for premarket approval applications and product development protocols oversteps the requirements of the Food, Drug & Cosmetic Act, the Health Industry Manufacturers Association (HIMA) asserts in recent comments to the agency.